Lenti-D ALD-102 (Version 2; Dated 30 January 2012)

• Research type

  Research Study

• Full title

  An open label, non-randomised, single dose, multi-center phase 2/3 study of the safety and efficacy of Lenti-D modified autologous stem cells for the treatment of subjects with cerebral adrenoleukodystrophy (CALD)

• IRAS ID

  91388

• Contact name

  Adrian Thrasher

• Contact email

  a.thrasher@ucl.ac.uk

• Sponsor organisation

  bluebirdbio, Inc.

• Eudract number

  2011-001953-10

• REC name

  London - West London & GTAC Research Ethics Committee

• REC reference

  GTAC187

• Date of REC Opinion

  4 Dec 2013

• REC opinion

  Further Information Favourable Opinion